5-(difluoromethyl)-1,3,4-thiadiazol-2-amine, 95+%, 25g

Benzyl (1-hydroxy-2-methylpropan-2-yl)carbamate, 97%, 5g

(S)-Benzyl (1-hydroxypropan-2-yl)carbamate, 95.0%, 25g

(S)-5'-Bromospiro[imidazolidine-4,1'-indene]-2,3',5(2'H)-trione, 97%, 100mg

tert-Butyl 2-azabicyclo[2.1.1]hexane-2-carboxylate, 95.0%, 100mg

Methyl 2-Chloro-D-mandelate>98.0%(GC)25g

4-Methoxycarbonylphenyl isothiocyanate, 98.0%, 100g

(2R,3R,4R)-3,4-Bis(benzyloxy)-2-((benzyloxy)methyl)-3,4-dihydro-2H-pyran, 97%, 250mg

(R)-1-(4-Morpholinophenyl)ethan-1-ol, 98%, 50mg

GC capillary column ROTI®Cap-1, 25 m, 0.53 mm, 0.50 µm, 1 Piece(s)

Methyl 5-Fluoro-4-methoxy-3-(trifluoromethyl)benzoate, 98%, 500mg

4-Methoxy-2-methylphenylacetonitrile, 97.0%, 1g

5,7-dichloro-8-fluoro-2-methylsulfanyl-1H-pyrido[4,3-d]pyrimidin-4-one, 97, 250mg